What are the limitations of the Biplane Simpson EF?

While the Biplane Simpson EF is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the Biplane Simpson EF to ensure safe bedside use and optimal diagnostic accuracy.

How does the Biplane Simpson EF compare to other Cardiovascular scores?

The Biplane Simpson EF is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the Biplane Simpson EF free to use?

Yes. OpiCalc provides the Biplane Simpson EF completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary LV systolic function assessment on transthoracic echo
HF diagnosis and severity stratification
Post-MI LV function assessment
Cardiotoxicity monitoring (chemotherapy, HER2 inhibitors)
Serial monitoring in LVAD candidates
More accurate than M-mode (Teichholz) in most patients

Key Advantages

Less dependent on geometric assumptions vs. M-mode
Validated against cardiac MRI gold standard
Incorporates regional function variations
Recommended by ESC/AHA guidelines as primary measurement
Reproducible across operators with good image quality

CLINICAL INSIGHT

How it Works

Calculation Methodology

Requires apical 2-chamber and 4-chamber views
Tracings of LV endocardium in diastole and systole
LV volume = Σ cylinder volumes stacked base-to-apex
Formula: EF = (EDV − ESV) / EDV × 100%
Biplane method averages 2- and 4-chamber calculations

LV EF Classification

LVEF (%)	Classification	Clinical Correlate
>50	Normal	No LV dysfunction
41–49	Mildly Reduced	HFmrEF (newer category)
31–40	Moderately Reduced	HFrEF (may be symptomatic)
≤30	Severely Reduced	HFrEF; high risk; LVAD/transplant candidate

CLINICAL INSIGHT

Practical Pearls

Technical Considerations

Image quality critical; foreshortened views → artifactually low EF
Apical thrombus can be included accidentally; visual assessment essential
Paradoxical septal motion (post-cardiac surgery) affects accuracy
Normal EF does NOT exclude diastolic dysfunction or HFpEF
Serial EF drop >5% during chemotherapy warrants intervention

Clinical Pitfalls

Foreshortened apical 4-chamber overestimates EF
Excessive papillary muscle inclusion underestimates volumes
Young athlete physiology (eccentric LV hypertrophy) may lower EF slightly
Tachycardia / arrhythmia reduces reproducibility; average multiple beats

CLINICAL INSIGHT

Next Steps

LVEF >50% (Normal)

Normal LV systolic function; reassess if new symptoms
Assess diastolic function if dyspnoea present
Standard follow-up based on clinical indication

LVEF 41–49% (Mildly Reduced / HFmrEF)

Offers risk for HF progression; optimize BP/HR
Consider SGLT2i therapy per recent guidelines
Annual echo surveillance
Identify and treat reversible causes

LVEF 31–40% (Moderately Reduced)

HFrEF diagnosis; initiate quadruple therapy: ACEi/ARB, β-blocker, MRA, SGLT2i
ICD evaluation if EF expected to remain ≤35% after 40 days therapy
CRT consideration if QRS ≥120 ms + symptoms
3–6 month repeat echo after therapy initiation

LVEF ≤30% (Severely Reduced)

High-risk HFrEF; aggressive pharmacotherapy + device therapy
ICD indicated for primary prevention if stable >40 days
Urgent cardiology consultation; evaluate LVAD/transplant candidacy
Monthly clinical monitoring; repeat echo every 3–6 months

Complementary Calculators

CLINICAL INSIGHT

Evidence Base

Validation

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Lang RM, et al.J Am Soc Echocardiogr.2015

CLINICAL INSIGHT

Background

Development

Biplane Simpson method has become the standard echocardiographic LV function assessment since the 1990s. Formalized in ASE guideline documents; now universal in echo labs worldwide.

Clinical Evidence and Methodology

Clinical Reference Hub

When to Use

When to Use

Key Advantages

How it Works

Calculation Methodology

LV EF Classification

Practical Pearls

Technical Considerations

Clinical Pitfalls

Next Steps

LVEF >50% (Normal)

LVEF 41–49% (Mildly Reduced / HFmrEF)

LVEF 31–40% (Moderately Reduced)

LVEF ≤30% (Severely Reduced)

Complementary Calculators

Evidence Base

Validation

Background

Development

Biplane Simpson EF

Clinical Reference Hub

When to Use

When to Use

Key Advantages

How it Works

Calculation Methodology

LV EF Classification

Practical Pearls

Technical Considerations

Clinical Pitfalls

Next Steps

LVEF >50% (Normal)

LVEF 41–49% (Mildly Reduced / HFmrEF)

LVEF 31–40% (Moderately Reduced)

LVEF ≤30% (Severely Reduced)

Complementary Calculators

Evidence Base

Validation

Background

Development

Clinical Evidence and Methodology

Clinical Reference Hub

When to Use

When to Use

Key Advantages

How it Works

Calculation Methodology

LV EF Classification

Practical Pearls

Technical Considerations

Clinical Pitfalls

Next Steps

LVEF >50% (Normal)

LVEF 41–49% (Mildly Reduced / HFmrEF)

LVEF 31–40% (Moderately Reduced)

LVEF ≤30% (Severely Reduced)

Complementary Calculators

Evidence Base

Validation

Background

Development

Biplane Simpson EF

Clinical Reference Hub

When to Use

When to Use

Key Advantages

How it Works

Calculation Methodology

LV EF Classification

Practical Pearls

Technical Considerations

Clinical Pitfalls

Next Steps

LVEF >50% (Normal)

LVEF 41–49% (Mildly Reduced / HFmrEF)

LVEF 31–40% (Moderately Reduced)

LVEF ≤30% (Severely Reduced)

Complementary Calculators